Tevogen Bio grants 8M restricted shares to CEO; total outstanding 193.7M shares

Tevogen Bio Holdings Inc.

Board approved restricted stock awards on June 27, 2025, including 8M shares to CEO Dr. Ryan Saadi.
Total outstanding shares now 193,693,433.
CEO's shares vest in four equal annual installments starting on the seventh anniversary of grant.
Other grantees' shares vest in three equal annual installments starting on the fifth anniversary.
Shares subject to forfeiture if continuous service not maintained; cannot be transferred before vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.